New investigational molecule discovered and developed collaboratively in the UK and Japan by Eisai Eisai in Europe today releases the first clinical data for E2609, a BACE (beta-site amyloid precursor protein-cleaving enzyme) inhibitor, presented during oral sessions at the Alzheimer's...